Suppr超能文献

知情同意权——治疗特权:前进的道路。

The need to know--therapeutic privilege: a way forward.

机构信息

Bioethics and Medical Jurisprudence, School of Law, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

出版信息

Health Care Anal. 2013 Jun;21(2):105-29. doi: 10.1007/s10728-012-0204-5.

Abstract

Providing patients with information is fundamental to respecting autonomy. However, there may be circumstances when information may be withheld to prevent serious harm to the patient, a concept referred to as therapeutic privilege. This paper provides an analysis of the ethical, legal and professional considerations which impact on a decision to withhold information that, in normal circumstances, would be given to the patient. It considers the status of the therapeutic privilege in English case law and concludes that, while reference is made to circumstances when information (primarily in relation to risk disclosure) may be withheld, further clarification is required on the status of therapeutic privilege. I suggest there has been shift in English law relating to the standard of information disclosure towards one set by the test of the reasonable, prudent patient. It is this shift that necessitates the existence of a therapeutic privilege which enables doctors to withhold information that would usually be given to the patient in order to prevent serious harm. I then explore the professional guidance in relation to information disclosure and how this relates to the legal position. There are strong ethical arguments in favour of disclosure of information to patients. In light of these, further clarification is required to identify and define the grounds on which this exception exists, the information that could lawfully be withheld and how this exception extends to rest of the health care team, particularly nurses. As such, explicit ethical and legal scrutiny of therapeutic privilege is needed in order to consider how this concept might be articulated, constrained and regulated.

摘要

向患者提供信息是尊重自主权的基础。然而,在某些情况下,可能会因为防止对患者造成严重伤害而需要隐瞒信息,这种情况被称为治疗特权。本文分析了影响是否隐瞒信息的伦理、法律和专业考虑因素,这些信息在正常情况下会提供给患者。本文考虑了治疗特权在英国案例法中的地位,并得出结论,尽管提到了在某些情况下可以隐瞒信息(主要是与风险披露有关的信息),但仍需要进一步澄清治疗特权的地位。我认为,英国法律在信息披露标准方面已经发生了变化,朝着以合理、谨慎的患者标准为基础的方向发展。正是这种转变,使得治疗特权的存在成为必要,它使医生能够为了防止严重伤害而隐瞒通常会提供给患者的信息。然后,我探讨了与信息披露相关的专业指导以及这与法律地位的关系。有强烈的伦理理由支持向患者披露信息。鉴于这些理由,需要进一步澄清,以确定和定义存在这种例外的理由、可以合法隐瞒的信息,以及这种例外如何扩展到医疗保健团队的其他成员,特别是护士。因此,需要对治疗特权进行明确的伦理和法律审查,以考虑如何阐述、限制和规范这一概念。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验